Formulation, Optimization, in vitro and in-vivo evaluation of levofloxacin hemihydrate Floating Tablets

Autores

  • Muhammad Sohail Arshad Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
  • Kiran Chaudhary Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
  • Jahanzeb Mudassir Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan https://orcid.org/0000-0002-7308-6509
  • Muhammad Farhan Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
  • Nasir Abbas College of Pharmacy, University of the Punjab, Lahore, Pakistan
  • Amjad Hussain College of Pharmacy, University of the Punjab, Lahore, Pakistan

DOI:

https://doi.org/10.1590/s2175-97902022e18630%20

Palavras-chave:

Gastroretentive dosage forms, Levofloxacin, Floating tablets, Carbopol 940, HPMC K4M

Resumo

The objective of the present investigation was to design, optimize and characterize the gastro retentive floating levofloxacin tablets and perform in-vivo evaluation using radiographic imaging. The floating tablets were prepared by using polymers i.e hydroxy propyl methyl cellulose (HPMC-K4M) and carbopol-940 individually and in combination by nonaquous granulation method. All the Formulations were evaluated for swelling index (S.I), floating behavior and in-vitro drug release kinetics. The compatibility study of levofloxacin with other polymers was investigated by FTIR, DSC, TGA and XRD. Results from FTIR and DSC revealed no chemical interaction amongst the formulation components. The optimized formulation (F11) showed floating lag time (FLT), total floating time (TFT) swelling index (S.I) of 60 sec, >16h and approximately 75 %, respectively. Moreover, F11 showed zero order levofloxacin release in simulated gastric fluid over the period of 6 h. X-ray studies showed that total buoyancy time was able to delay the gastric emptying of levofloxacin floating tablets in rabbits for more than 4 hours. In conclusion the optimized formulation (F11) can be used for the sustained delivery of levofloxacin for the treatment of peptic ulcer.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. Aaps PharmSciTech. 2005;6(3):E372-E390.

Bahri-Najafi R, Mostafavi A, Tavakoli N, Taymouri S, Shahraki M-M. Preparation and in vitro-in vivo evaluation of acyclovir floating tablets. Res Pharm Sci. 2017;12(2):128.

Bansal S, Beg S, Garg B, Asthana A, Asthana GS, Singh B. QbD-oriented development and characterization of effervescent floating-bioadhesive tablets of cefuroxime axetil. AAPS Pharm Sci Tech. 2016;17(5):1086-1099.

Bettini R, Colombo P, Massimo G, Catellani PL, Vitali T. Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur J Pharm Sci. 1994;2(3):213-219.

Bhardwaj L, Sharma PK, Malviya R. A short review on gastro retentive formulations for stomach specific drug delivery: special emphasis on floating in situ gel systems. Afr J Basic Appl Sci. 2011;3(6):300-312.

Blondeau J, Laskowski R, Bjarnason J, Stewart C. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. Int J Antimicrob Agents. 2000;14(1):45-50.

Diós P, Szigeti K, Budán F, Pócsik M, Veres DS, Máthé D, et al. Influence of barium sulfate X-ray imaging contrast material on properties of floating drug delivery tablets. Eur J Pharm Sci . 2016;95:46-53.

Dudhipala N, Narala A, Janga K, Bomma R. Amoxycillin trihydrate floating-bioadhesive drug delivery system for eradication of Helicobacter pylori: Preparation, in vitro and ex vivo evaluation. J Bioequiv Availab. 2016;8(3):118-124.

El-Zahaby SA, Kassem AA, El-Kamel AH. Design and evaluation of gastroretentive levofloxacin floating mini- tablets-in-capsule system for eradication of Helicobacter pylori. Saudi Pharm J. 2014a;22(6):570-579.

El-Zahaby SA, Kassem AA, El-Kamel AH. Formulation and in vitro evaluation of size expanding gastro-retentive systems of levofloxacin hemihydrate. Int J Pharm. 2014b;464(1-2):10-18.

Essa EA, Elkotb FE, Eldin EEZ, El Maghraby GM. Development and evaluation of glibenclamide floating tablet with optimum release. J Drug Delivery Sci Technol. 2015;27:28-36.

Gharti K, Budhathoki U, Thapa P, Bhargava A. Formulation in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm. 2012;4(4):201-208.

Gorman EM, Samas B, Munson EJ. Understanding the dehydration of levofloxacin hemihydrate. J Pharm Sci. 2012;101(9):3319-3330.

Hadjiioannou TP, Christian GD, Koupparis MA, Macheras PE. Quantitative calculations in pharmaceutical practice and research: VCH New York; 1993.

Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci . 1963;52(12):1145-1149.

Kshirsagar R, Jain V, Wattamwar S. Effect of different viscocity grade HPMC polymers on gastroretantive drug delivery of Metformin HCl. Int J Appl Pharm. 2009;1:44-50.

Panda B, Subhadarsini R, Mallick S. Biointerfacialphenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: correlation of swelling and drug delivery performance. Expert Opin Drug Delivery. 2016;13(5):633-643.

Patel A, Modasiya M, Shah D, Patel V. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. AAPS PharmSciTech. 2009;10(1):310-315.

Patel V, Patel N, Yeole P. Studies on formulation and evaluation of ranitidine floating tablets. Indian J Pharm Sci . 2005;67(6):703.

Patel VF, Patel NM. Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation. AAPS PharmSciTech . 2006;7(1):E118-E124.

Patil H, Tiwari RV, Repka MA. Recent advancements in mucoadhesive floating drug delivery systems: A mini-review. J Drug Delivery Sci Technol . 2016;31:65-71.

Patil J. Design and evaluation of gastro retentive drug delivery system of anti ulcer drug. J Food Pharm Sci. 2015;3(1).

Porwal A, Dwivedi H, Pathak K. Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy. Braz J Pharm Sci . 2017;53(3).

Raghavendra Rao NG, Ram P, Kethan T, Suryakar V. Formulation and in vitro evaluation of gastric oral floating tablets of cefixime for controlled release. Res J Pharm, Biol Chem Sci. 2010;1(3)141-154.

Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev Ind Pharm. 2000;26(9):913-924.

Vemula SK, Venisetty RK, Veerareddy PR. Valsartan floating bioadhesive compression-coated mini-tablets: Formulation and pharmacokinetics. J Drug Delivery Sci Technol . 2017;40:66-72.

Venkateswarlu K. Formulation Development and In-vitro Evaluation of Floating Tablets of Ciprofloxacin HCl. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2016;10(04).

Verma A, Dubey J, Hegde RR, Rastogi V, Pandit J. Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems. J Drug Target. 2016;24(10):897-915.

Wong PS, Dong L-C, Edgren DE, Theeuwes F, Gardner PI, Jao F, et al. Prolonged release active agent dosage form adapted for gastric retention. Google Patents. 2000.

Zaini E, Fitriani L, Effendy S, Noviza D, Halim A. Preparation and Characterization of Solid Dispersion Telmisartan- Hydroxypropyl Methyl Cellulose (HPMC) E5 LV by Co-Grinding Method. Orient J Chem. 2017;33(2):873-8.

Downloads

Publicado

2022-12-23

Edição

Seção

Original Article

Como Citar

Formulation, Optimization, in vitro and in-vivo evaluation of levofloxacin hemihydrate Floating Tablets. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e18630